Nav: Home

Springer to publish new journal Systems and Synthetic Biology

November 22, 2006

Springer, one of the world's leading science, technology and medicine (STM) publishers, will launch a new quarterly journal in 2007 called Systems and Synthetic Biology (SSB). The addition of this journal to the publishing program will strengthen Springer's growing biomedical sciences portfolio.

Systems and Synthetic Biology will publish contributions that either advance the field of synthetic biology as an engineering discipline or use it to improve the scientific knowledge of existing phenomena. Original papers, reviews, methodology articles, software articles and commentaries will provide a platform for the exchange and dissemination of knowledge in this emerging field. A special feature of the journal will be the online publication of supplementary material such as three-dimensional figures, sequence data and alignments, animations and short videos. The Editors-in-Chief Dr. Pawan K. Dhar of the RIKEN Genomic Sciences Center in Kanagawa, Japan and Professor Ron Weiss of Princeton University, Princeton, NJ, USA will be supported by an international editorial board.

Ron Weiss, commenting on this field, said, "The shared goals of systems biology and synthetic biology are to gain a fundamental understanding of cellular processes and create new cell circuits using a combination of experimental, theoretical and computational approaches." Citing the new journal, Pawan K. Dhar continued, "SSB will provide a unique home for experimental systems and synthetic biology and offer adequate coverage for theoretical work."

Peter Butler, Editorial Director for Life Sciences at Springer, said, "We are very pleased, not only to strengthen our existing portfolio of journals, but also proud to offer the research community, from a diverse range of disciplines, a forum to publish their research results in systems and synthetic biology."

Springer will publish Systems and Synthetic Biology in both electronic and print formats to serve the needs of librarians and readers around the world. All articles will be published online via Online First™, a feature that allows authors to bring their work to the attention of their peers at a very early stage of the publication process. In addition, all potential SSB authors have the option, via the Springer Open Choice program, of publishing their articles using the open access publishing model once they have been accepted for publication.
-end-
Springer is the second-largest publisher worldwide in the science, technology, and medicine (STM) sector. Springer is part of Springer Science+Business Media, one of the world's leading suppliers of scientific and specialist literature. The group owns 70 publishing houses, together publishing a total of 1,450 journals and more than 5,000 new books a year. The group operates in over 20 countries in Europe, the USA, and Asia, and has some 5,000 employees. In 2005, it generated annual sales of around EUR 838 million.

Springer

Related Synthetic Biology Articles:

Cell-free synthetic biology comes of age
In a review paper published in Nature Reviews Genetics, Professor Michael Jewett explores how cell-free gene expression stands to help the field of synthetic biology dramatically impact society, from the environment to medicine to education.
Scientists develop electrochemical platform for cell-free synthetic biology
Scientists at the University of Toronto (U of T) and Arizona State University (ASU) have developed the first direct gene circuit to electrode interface by combining cell-free synthetic biology with state-of-the-art nanostructured electrodes.
Gene-OFF switches tool up synthetic biology
Wyss researchers and their colloaborators have developed two types of programmable repressor elements that can switch off the production of an output protein in synthetic biology circuits by up to 300-fold in response to almost any triggering nucleotide sequence.
Tennessee researchers join call for responsible development of synthetic biology
Engineering biology is transforming technology and science. Researchers in the international Genome Project-write, including two authors from the UTIA Center for Agricultural Synthetic Biology, outline the technological advances needed to secure a safe, responsible future in the Oct.
Scientists chart course toward a new world of synthetic biology
A UC Berkeley team with NSF funding has compiled a roadmap for the future of synthetic or engineering biology, based on the input of 80 leaders in the field from more than 30 institutions.
DFG presents position paper on synthetic biology
Clear distinction between synthetic biology and underlying methods required / No new potential risks associated with current research work
Commandeering microbes pave way for synthetic biology in military environments
A team of scientists from the US Army Research Laboratory and the Massachusetts Institute of Technology have developed and demonstrated a pioneering synthetic biology tool to deliver DNA programming into a broad range of bacteria.
BioBits: Teaching synthetic biology to K-12 students
As biologists have probed deeper into the genetic underpinnings of life, K-12 schools have struggled to provide a curriculum that reflects those advances.
Sensor strategy a boon for synthetic biology
Rice University synthetic biologists have invented a technology to dial up or down the sensitivity of bacterial biosensors.
Drug-producing bacteria possible with synthetic biology breakthrough
Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles, from the University of Warwick and the University of Surrey.
More Synthetic Biology News and Synthetic Biology Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Clint Smith
The killing of George Floyd by a police officer has sparked massive protests nationwide. This hour, writer and scholar Clint Smith reflects on this moment, through conversation, letters, and poetry.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.